Our response to the "SARS-Cov-2 (Coronavirus) infection"
In order to prevent the spread of the new coronavirus, we are implementing telecommuting,
strengthening hygiene management, and reviewing our business system.
We will respond flexibly in anticipation of major changes in the future.
Therefore, it may take some time for us to respond to your inquiries and other inquiries.
We apologize for any inconvenience this may cause and thank you for your understanding.
【June 22th, 2020】
Our company's project in collaboration with the University of Tokyo, University of Tsukuba, and Axis Corporation
was adopted as part of the Ministry of Economy, Trade and Industry's "Strategic Basic Technology Advancement
Support Project ( (Sapoin project, total grant amount: 97.5 million yen).
We will continue to promote further research and development and social implementation.
【URL for reference (Only in Japanese) :
【Project management company : Axis Co,,Ltd URL (Only in Japanese): https://www.axisjp.co.jp/
【February 7th, 2020】
Our company has signed a joint research agreement with Takeuchi Laboratory, Environmental Microbiology, Medical Sciences in University of Tsukuba, Japan on January 29th, 2020 to develop advanced biotechnology using reverse genetics and viruses.
【January 24th, 2020】
Joint clinical research program with Kansai Electric Power Hospital (Osaka city, Osaka prefecture, Japan) was approved by the Kansai Electric Power Hospital's Ethics Review Committee. We will develop artificial intelligence (AI) for medicine and information analysis.
【December 24th, 2019】
【Information for winter recess】
Our company will be in winter recess between Dec. 31th, 2019 and Jan. 5th, 2020.
【December 20th, 2019】
Our new joint research and development website has been released.
【November 22th, 2019】
Our company has signed a joint research contract with The Health Nutrition Laboratory (Department of Applied Biological Chemistry, Graduate school of Agricultural and Life Sciences, The University of Tokyo, Japan) on November 1st, 2019 to conduct joint research and development in the areas of life sciences, health and high speed biochemical analysis technology.
【October 29th, 2019】
Our company has been selected as a manufacturing support project (test research subsidy project) by Hirosawa Foundation for technology (Ibaraki prefecture, Japan).
Our company will continue further research and development.
【September 3rd, 2019】
Our company and Prof. Yasuo Yoshimi laboratory from Shibaura Institute of Technology have been working together on the research theme; the chip formation of molecularly imprinted polymer fixed carbon electrode. This joint research project has been adopted this year by the Adaptable and Seamless Technology transfer Program through target driven R&D (A-STEP), offered by Japan Science and Technology Agency. We aim for practical use taking advantage of our collaboration and this official support for example development of sensor for drugs contained in patients’ blood samples or imported foods.
【August 30th, 2019】
Our company built a deep learning server for pathological slides analysis. As an example, it was achieved an identification rate of 97% or higher in pathological slide images of lung cancer patient and healthy patient subjects. In the future, our company will work with doctors and other specialists to further research and develop the technology.
【August 26th, 2019】
Our company has signed a joint research and development agreement (MOU) with Indian Institute of Technology Madras, Chennai, India on 26th July 2019 to conduct international joint research and development in the areas of medicine and life sciences.
【August 1st, 2019】
The second supplementary budget project “Small Business Sustainability Subsidy” was adopted for our overseas business.
【Feburary 20th, 2019】
In Tsukuba City Hall, the demonstration of Portable Blood analysis device will be held on February 26 as the tsukuba society 5.0 social implementation trial support project.
Reference Site: Tsukuba City Website（http://www.city.tsukuba.lg.jp/_res/projects/default_project/_page_/001/005/695/No276.pdf）
【Feburary 4th, 2019】
An ethics review committee (committee name: Blue Industries Inc. Ethics Review Committee) consisting of
various experts (medical doctors, clinical laboratory technicians, lawyers, veterinarians and etc.) was established.
It was registered in the research ethics review committee reporting system of Japan Agency for Medical research and Development (AMED).
【December 17th, 2018】
- Notice of Winter Closure -
Our company will be closed from December 29th(Sat), 2018 to January 2nd(Wed), 2019.
For the inquiries and etc, we will correspond after the holiday. We appreciate your understanding.
【December 7th, 2018】
Our Company signed an agreement of technical development and demonstration experiment for biochemical analysis kit with City of Tsukuba in Ibaraki prefecture, Japan. We will proceed with demonstration experiments for biochemical analysis kits in collaboration with City of Tsukuba.
【November 22th, 2018】
We opened a website for collaborative research & development and social implementation experiment.
English URL: http://blue-joint-project.com/en
Japanese URL: http://blue-joint-project.com/jp
【November 18th, 2018】
R & D results of biochemical analysis devices presented at the 65 th Annual Meeting of the Japanese Association of Clinical Medicine Academic Societies
(Date: November 15 (Thu) - November 18 (Sun), 2018 November, Sunday, venue: Keio Plaza Hotel).
It is a joint research and development result of university researcher (Two national universities in Japan, one ivy league university in the United States), Uno Information Management Institute and our company.
【August 28th, 2018】
We announced at the 2nd review of Tsukuba Society 5.0 Social Implementation Trial Support Project and was adopted this time.
We will promote further research and development and business development in the future to implement new technologies socially.
(Adopted theme name: Social implementation experiment using portable blood analysis device ~ Toward realization of a self-care society aimed at reducing medical expenses ~)
【August 10th, 2018】
Dr. Kayoko Shioda (affiliated to Yale University, USA) of our Infectious Immunization and Epidemiology Research Project Manager served as one of Japan representatives at the 68th Lindau-Nobel Prize Winner Conference (Physiology and Medicine) held in Germany in June I participated. She gave a close discussion with young researchers from 84 countries and 39 Nobel laureates.
【August 1st, 2018】
Our proposal project passed the primary review of the Tsukuba Society 5.0 social implementation trial support project.
It was decided to present at the final examination (presentation examination). It will be announced on August 28 at Tsukuba Capio Hall.
【July 19th, 2018】
We have been adopted as a supplementary budget for Small-scale business sustainability subsidy
【July 2nd, 2018】
We will present R&D resuls at the 65th Annual Meeting of the Japan Society of Clinical Medicine Academic Society (Date: November 2018 It will be announced at Thursday 15th - November 18th (Sunday), the venue: Keio Plaza Hotel, Tokyo Japan).
【January 4th, 2018】
Our company's research and development project (portable blood analysis device) was approved at the ethics review committee of the University of Tsukuba Hospital (National University Hospital in Japan). We will continue practical clinical research.
【December 8th, 2017】
Our company has concluded a collaborative research agreement with University of Tsukuba.
We will conduct research and development of new medical devices with the University of Tsukuba medical and sports medicine laboratory.
【October 4th, 2017】
Strategic Basic Technology Advancement Support Project (Sapon Business) was started.
【July 28h, 2017】
Our research and development theme was adopted in Strategic Basic Technology Advancement Support Project (Sapon Business). We will further advance research and development.
【July 27th, 2017】
Our R&D project was certified by the Ministry of Economy, Trade and Industry, Ministry of Economy, Trade and Industry.
【July 25th, 2017】
A prototype system of Infectious Disease · Medical · Environmental Information Integrated Analysis System (Blue Spider) was completed. We will promote the development of an early warning prediction system such as infectious epidemics.
【July 24th, 2017】
Hachinohe City Growth Industry Location etc. subsidy support project was adopted. We will make use of it in research development at Tohoku office (Hachinohe city).
【July 24th, 2017】
Aomori Prefecture Medical Industry Collaboration Promotion Project Grant Subsidy was adopted. We will utilize it in research and development related to medical treatment, infectious diseases, etc., mainly in Aomori prefecture.
【March 17th, 2017】
It’s adopted the Small Scale Business Sustainability Grant.
【March 17, 2017】
It’s adopted innovative manufacturing, commerce and service development support grant.
【March 10, 2017】
It’s adopted IT product introduction support grant. We will further improve productivity by utilizing IT.
【January 31, 2017】
Our management reform plan was approved. (Planned period: five-year plan by governor of Tokyo metropolitan office.
【January 15, 2017】
We decided to set up a research base to conduct research on medical technology, life science etc. in Hachinohe city, Aomori prefecture. We will further promote business expansion and R & D.
【December 1, 2016】
The headquarters moved from Sumida Ward Yahiro to the Arkacentral Building in Kinshicho Sumida Ward
【November 24, 2016】
From the Ministry of Economy, Trade and Industry(METI) Kanto Bureau, Japan , a management capacity improvement plan was certified.
【August 22, 2016】
State-of-the-art 3D printer "AGILISTA-3200" was installed and supported by Tokyo Higashi shinkin bank head office,Japan Finance Corporation Ueno branch and Small and Medium Enterprise Agency (Manufacturing support finance), Keyence Co. Ltd, Japan. After the installation soon, we have received a large number of research and development and design request from medical professionals. We have established a system to allow such a wide range of corresponding machinery, mechanism and exterior design. Consultation of the design and development is thank you to the left of the contact. (E-mail: contact @ blueindustries.co.jp)
【June 6, 2016】
Adopted as an auxiliary company of the 2015 supplementary budget manufacturing, commercial and service new development support subsidy”from Ministry of Economy, Trade and Industry, Japan.
We will promote further research and development.
【April 12, 2016】
Certified as the University of Tsukuba startup company.
【April 1, 2016】
Zeon Nanotechnology Co., Ltd. provide a carbon nanotube, and started the development of new products.
【November 1, 2015】
Started a joint research and development with Japan Tobacco Inc.
【August 18, 2015】
Head office was established in Sumida-ku, Tokyo Yahiro.